Regenesis Biomedical Expands Clinical Resources by Appointing Medical Director
Extending clinical reach and awareness of Provant pulsed radio frequency energy.
Scottsdale, Arizona, July 19, 2011 — Regenesis Biomedical, Inc., a medical technology company that markets the Provant® Therapy System, announced today Dr. Adrianne (Patti) Smith, MD, joined the company as Medical Director. In her new role, Dr. Smith will further develop the clinical awareness of the therapeutic effectiveness of pulsed radiofrequency energy (PRFE). A renowned leader in medical education, she is also responsible for developing best clinical practices to improve patient access and Provant Therapy utilization.
Dr. Smith gained industry experience in her positions as Vice President and Medical Director at Kinetic Concepts Inc. (KCI), the marketer of the wound V.A.C., and Senior Medical Advisor at Diversified Clinical Services (DCS), supporting the clinical outreach of the largest US wound care and hyperbaric oxygen management company. Dr. Smith’s academic appointments have included the University of Texas Health Science Center Emergency Department, where she served as the Quality Risk Management Director; the Chief of Emergency Services for Scott Air Force Base; and the Medical Director of the Texas Diabetes Institute hyperbaric medicine and wound care center. A graduate of Duke University and Washington University Medical School, Dr. Smith has authored numerous publications and is a co-Editor of Wound Care Practice. “We are pleased Patti chose Regenesis to apply her clinical knowledge to help expand patient access to Provant Therapy,” said Richard Isenberg, MD, Vice President of Clinical and Regulatory Affairs of Regenesis. “Her commitment to clinicians and their patients supports our core value of compassion.” “As we meet the challenging demands of providing healthcare in the community,” Dr. Smith acknowledges, “it is important that clinicians have a clear understanding of all medical therapeutics available for their patients, including PRFE.”
About Regenesis Biomedical
Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.
About the Provant® Therapy System
Provant uses pulsed radio frequency energy (PRFE) to
facilitate reduction of the pain and edema associated with post-operative,
superficial soft tissues.
SOURCE: Regenesis Biomedical Inc.